title: Type I procollagen: the gene-protein system that harbors most of the mutations causing osteogenesis imperfecta and probably more common heritable disorders of connective tissue.
abstract: Recent data from several laboratories have established that most variants of osteogenesis imperfecta (OI) are caused by mutations in the 2 structural genes for type I procollagen. There are 2 general reasons for the large number of mutations in type I procollagen in OI. One reason is that most of the structure of the procollagen monomer is essential for normal biological function of the protein. The second reason is that most of the mutations cause synthesis of structurally altered pro alpha chains of type I procollagen. The deleterious effects of the structurally altered pro alpha chains are then amplified by at least 3 mechanisms. One mechanism is a phenomenon referred to as "procollagen suicide" whereby altered pro alpha chains cause degradation of normal pro alpha chains synthesized by the same cell. Another mechanism involves the fact that many of the structurally altered pro alpha chains prevent normal processing of the N-propeptides of procollagen and persistence of the N-propeptide interferes with normal fibril assembly. A third mechanism is a recently discovered phenomenon in which a substitution of a bulkier amino acid for glycine can cause a kink in the triple helix of the molecule. The kinked collagen, in turn, causes formation of abnormally branched fibrils. Because the deleterious effects of abnormal pro alpha chains are amplified by these 3 mechanisms, most of the mutations are dominant and many are dominant lethal. The conclusion that most variants of OI are caused by mutations in the structural genes for type I procollagen has broad implications for other diseases that affect connective tissue, diseases such as chondrodystrophies, osteoarthritis, and osteoporosis.
authors.affiliation: Department of Biochemistry and Molecular Biology, Jefferson Institute of Molecular Medicine, Jefferson Medical College, Philadelphia, PA 19107.
authors.forename: D J
authors.initials: DJ
authors.lastname: Prockop
authors.forename: C D
authors.initials: CD
authors.lastname: Constantinou
authors.forename: K E
authors.initials: KE
authors.lastname: Dombrowski
authors.forename: Y
authors.initials: Y
authors.lastname: Hojima
authors.forename: K E
authors.initials: KE
authors.lastname: Kadler
authors.forename: H
authors.initials: H
authors.lastname: Kuivaniemi
authors.forename: G
authors.initials: G
authors.lastname: Tromp
authors.forename: B E
authors.initials: BE
authors.lastname: Vogel
mesh_terms: D000595:Amino Acid Sequence; D001483:Base Sequence; D003240:Connective Tissue Diseases / Q000235:genetics* / Q000378:metabolism; D006801:Humans; D008969:Molecular Sequence Data; D009154:Mutation; D010013:Osteogenesis Imperfecta / Q000235:genetics* / Q000378:metabolism; D011347:Procollagen / Q000096:biosynthesis / Q000235:genetics*
chemical_list: D011347:Procollagen